Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

News Industry News

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

May 25, 2017

Presentation JIM 2017

Simple and Complex Bifurcation Cases

Presenter: Robert-Jan van Geuns

February 23, 2017

Presentation JIM 2017

Managing Calcified Lesions

Presenter: Robert-Jan van Geuns

February 08, 2017

Presentation JIM 2017

ABSORB Lessons From Registries: Outcome Influenced by Experience and Technique

Presenter: Robert-Jan van Geuns

February 08, 2017

Presentation TCT 2016

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results

Presenter: Gary S. Mintz, Robert-Jan van Geuns, Fernando Alfonso

November 02, 2016

Presentation TCT 2016

TRANSFORM-OCT: A Prospective, Randomized Trial Using OCT Imaging to Evaluate Strut Coverage at Three Months and Neoatherosclerosis at Eighteen Months in Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

Presenter: Gary S. Mintz, Robert-Jan van Geuns, Giulio Guagliumi

November 02, 2016

Presentation TCT 2016

TOSCA-5: A Prospective, Randomized Trial Evaluating Collagenase Infusion in Patients With Coronary Artery Chronic Total Occlusions

Presenter: Gary S. Mintz, Robert-Jan van Geuns, Christopher E. Buller

November 02, 2016

Presentation TCT 2016

PRISON IV: A Prospective, Randomized Trial of a Bioresorbable Polymer-Based Sirolimus-Eluting Stent and a Durable Polymer-Based Everolimus-Eluting Stent in Patients With Coronary Artery Chronic Total Occlusions

Presenter: Gary S. Mintz, Robert-Jan van Geuns, Koen Teeuwen

November 02, 2016

Presentation EuroPCR 2016

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

Presenter: Robert-Jan van Geuns

May 18, 2016

News Conference News EuroPCR 2016

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Michael O'Riordan

May 17, 2016

News Industry News

STENTYS Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years(1)

October 12, 2015

News Industry News

Follow-up imaging data from APPOSITION IV study to be presented at TCT conference in San Francisco

October 12, 2015

Presentation BRS 2015

A Complex STEMI

Presenter: Robert-Jan van Geuns

February 10, 2015

Presentation TCT 2014

Absorb III/IV: Testing Noninferiority and Superiority

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Dean J. Kereiakes

September 16, 2014

Presentation TCT 2014

Absorb III/IV: Angina and Ischemia Hypotheses

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Gregg W. Stone

September 16, 2014

Presentation TCT 2014

Update: The EXTEND Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Alexandre Abizaid

September 16, 2014

Presentation TCT 2014

Update: The Absorb ASSURE Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Thomas Schmitz

September 16, 2014

Presentation TCT 2014

Update: The Absorb GHOST Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Corrado Tamburino

September 16, 2014

Presentation TCT 2014

Update: The Absorb FIRST Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Christoph K. Naber

September 16, 2014

Advertisement

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

Simple and Complex Bifurcation Cases

Managing Calcified Lesions

ABSORB Lessons From Registries: Outcome Influenced by Experience and Technique

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results

TRANSFORM-OCT: A Prospective, Randomized Trial Using OCT Imaging to Evaluate Strut Coverage at Three Months and Neoatherosclerosis at Eighteen Months in Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

TOSCA-5: A Prospective, Randomized Trial Evaluating Collagenase Infusion in Patients With Coronary Artery Chronic Total Occlusions

PRISON IV: A Prospective, Randomized Trial of a Bioresorbable Polymer-Based Sirolimus-Eluting Stent and a Durable Polymer-Based Everolimus-Eluting Stent in Patients With Coronary Artery Chronic Total Occlusions

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

STENTYS Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years(1)

Follow-up imaging data from APPOSITION IV study to be presented at TCT conference in San Francisco

A Complex STEMI

Absorb III/IV: Testing Noninferiority and Superiority

Absorb III/IV: Angina and Ischemia Hypotheses

Update: The EXTEND Real-World Registry

Update: The Absorb ASSURE Real-World Registry

Update: The Absorb GHOST Real-World Registry

Update: The Absorb FIRST Real-World Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content